Lead Independent Board Director
CurrentBoard member of this NASDAQ traded company since March 2013. Elected to lead independent director in March 2014. Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. The company’s products, which are sold throughout the United States and internationally, have improved outcomes for more than five million patients globally by reducing infections, itch, pain, scarring and harmful inflammatory responses.